Side-by-side comparison of AI visibility scores, market position, and capabilities
PepsiCo's high-caffeine citrus soft drink with 54mg caffeine and gamer marketing culture; "Dew Nation" loyal following with 20+ flavors competing with Coke's variants for young male energy.
Mountain Dew is a high-caffeine citrus-flavored carbonated soft drink owned by PepsiCo (NASDAQ: PEP) — one of the most distinctive soft drink brands in the US, known for its electric green color, intense sweetness, and significantly higher caffeine content than other sodas (54mg per 12oz vs. Coca-Cola's 34mg). Mountain Dew targets young male consumers, gamers, and extreme sports enthusiasts with marketing positioning around energy, adventure, and gaming culture. Frito-Lay North America, the Frito-Lay business, and Mountain Dew together form PepsiCo's North America Beverages segment.\n\nMountain Dew's product line extends well beyond the original citrus flavor — the brand has proliferated with Code Red (cherry), Voltage (raspberry citrus), Baja Blast (tropical lime, exclusive to Taco Bell), White Out, Major Melon, and seasonal and limited releases that generate significant retail excitement and social media engagement. The gaming partnership strategy (Major League Gaming, game sponsorships, gamer content creators) has been central to Mountain Dew's marketing for over a decade, creating authentic presence in the gaming community. MTN DEW Rise Energy competes in the energy drink segment.\n\nIn 2025, Mountain Dew competes with Coca-Cola's brands (Mello Yello, Surge) and energy drinks (Monster, Red Bull) for the high-caffeine/energy-adjacent soft drink market. The carbonated soft drink market faces secular decline as consumers shift toward water, energy drinks, and better-for-you beverages — Mountain Dew's intensely loyal customer base (Dew Nation) provides resilience against this trend, as passionate brand advocates continue consumption despite broader category softness. PepsiCo's 2025 strategy for Mountain Dew focuses on flavored variety launches driving trial, gaming sponsorship maintaining cultural relevance, and growing MTN DEW Rise Energy in the expanding energy drink category.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.